Physician profile
Nathan Coleman
NPI 1497008759
$7,954.44
in general payments reported to CMS, 2019-2025
31 companies · $1,805 in 2025
The $1,805 reported for 2025 was more than what 82% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,092 · 2020: $232 · 2021: $399 · 2022: $2,695 · 2023: $1,096 · 2024: $637 · 2025: $1,805.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,851 · Travel and Lodging: $1,687.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,850.68 |
| Travel and Lodging | $1,687.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gentleman Orthopedic Solutions | $3,998.36 | 2019-2025 | |
| Treace Medical Concepts, INC. | $1,332.02 | 2022-2025 | |
| Paratek Pharmaceuticals, INC. | $372.29 | 2022-2025 | Nuzyra |
| Kerecis Limited | $235.39 | 2021-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Smith+Nephew, INC. | $213.69 | 2019-2022 | |
| Arthrex, INC. | $206.40 | 2023 | |
| Organogenesis INC. | $206.13 | 2020-2022 | |
| Amgen INC. | $190.36 | 2024-2025 | Krystexxa |
| Abbvie INC. | $175.93 | 2021-2025 | Dalvance |
| Melinta Therapeutics, LLC | $147.44 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $125.16 | 2020-2025 | Jublia |
| Horizon Therapeutics Plc | $124.49 | 2020-2021 | |
| Bioventus LLC | $90.95 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Averitas Pharma INC. | $68.44 | 2023-2024 | Qutenza |
| Nevro Corp. | $63.90 | 2023-2024 | Senza |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $58.90 | 2019 | |
| Stryker Corporation | $46.17 | 2022 | |
| Orthofix Medical, INC. | $45.21 | 2019-2021 | |
| Depuy Synthes Sales INC. | $37.71 | 2019-2022 | |
| Cashflow Solutions, LLC | $25.51 | 2024-2025 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Boston Scientific Corporation | $25.39 | 2024 | Wavewriter Alpha Prime 16 |
| Vertex Pharmaceuticals Incorporated | $25.06 | 2025 | |
| Sanara Medtech INC. | $19.72 | 2021 | |
| Abbott Laboratories | $17.68 | 2024 | Proclaim |
| Wright Medical Technology, INC. | $17.46 | 2019 | |
| Acera Surgical, INC. | $17.16 | 2021 | |
| Reprise Biomedical, INC. | $15.34 | 2024 | Miro3d |
| Assertio Therapeutics, INC. | $14.44 | 2020 | |
| Grt US Holding, INC. | $13.31 | 2021 | |
| Crossroads Extremity Systems, LLC | $12.86 | 2021 | |
| Advanced Oxygen Therapy INC. | $11.57 | 2024 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Coleman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.